Publications
Detailed Information
Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, So Yeon | - |
dc.contributor.author | Lee, Hee Eun | - |
dc.contributor.author | Li, Hailun | - |
dc.contributor.author | Shipitsin, Michail | - |
dc.contributor.author | Polyak, Kornelia | - |
dc.contributor.author | Gelman, Rebecca | - |
dc.date.accessioned | 2012-05-31T06:30:00Z | - |
dc.date.available | 2012-05-31T06:30:00Z | - |
dc.date.issued | 2010-02-01 | - |
dc.identifier.citation | CLINICAL CANCER RESEARCH; Vol.16 3; 876-887 | ko_KR |
dc.identifier.issn | 1078-0432 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76689 | - |
dc.description.abstract | Purpose: To evaluate the expression of stem cell-related markers at the cellular level in human breast tumors of different subtypes and histologic stage. Experimental Design: We performed immunohistochemical analyses of 12 proteins [CD44, CD24, ALDH1, vimentin, osteonectin, EPCR, caveolin 1, connexin 43, cytokeratin 18 (CK18), MUC1, claudin 7, and GATA3] selected based on their differential expression in breast cancer cells with more differentiated and stem cell-like characteristics in 47 cases of invasive ductal carcinoma (IDC) only, 135 cases of IDC with ductal carcinoma in situ (DCIS), 35 cases of DCIS with microinvasion, and 58 cases of pure DCIS. We also analyzed 73 IDCs with adjacent DCIS to determine the differences in the expression of markers by histology within individual tumors. CD44+/CD24- and CD24-/CD24+ cells were detected using double immunohistochemistry. Results: CD44 and EPCR expression was different among the four histologic groups and was lower in invasive compared with in situ tumors, especially in luminal A subtype. The expression of vimentin, osteonectin, connexin 43, ALDH1, CK18, GATA3, and MUC1 differed by tumor subtype in some histologic groups. ALDH1-positive cells were more frequent in basal-like and HER2+ than in luminal tumors. CD44+/CD24- cells were detected in 69% of all tumors with 100% of the basal-like and 52% of HER2+ tumors having some of these cells. Conclusions: Our findings suggest that in breast cancer, the frequency of tumor cells positive for stem cell-like and more differentiated cell markers varies according to tumor subtype and histologic stage. Clin Cancer Res; 16(3); 876-87. (C) 2010 AACR. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | AMER ASSOC CANCER RESEARCH | ko_KR |
dc.subject | breast cancer | ko_KR |
dc.subject | tumor progression | ko_KR |
dc.subject | DCIS | ko_KR |
dc.subject | heterogeneity | ko_KR |
dc.title | Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 박소연 | - |
dc.contributor.AlternativeAuthor | 이희은 | - |
dc.identifier.doi | 10.1158/1078-0432.CCR-09-1532 | - |
dc.citation.journaltitle | CLINICAL CANCER RESEARCH | - |
dc.description.citedreference | Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017 | - |
dc.description.citedreference | Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106 | - |
dc.description.citedreference | Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000 | - |
dc.description.citedreference | Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837 | - |
dc.description.citedreference | Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441 | - |
dc.description.citedreference | Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741 | - |
dc.description.citedreference | Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499 | - |
dc.description.citedreference | Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207 | - |
dc.description.citedreference | Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105 | - |
dc.description.citedreference | Xiao Y, 2008, AM J PATHOL, V173, P561, DOI 10.2353/ajpath.2008.071214 | - |
dc.description.citedreference | Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018 | - |
dc.description.citedreference | Mylona E, 2008, HUM PATHOL, V39, P1096, DOI 10.1016/j.humpath.2007.12.003 | - |
dc.description.citedreference | Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027 | - |
dc.description.citedreference | Hyun CL, 2008, J CLIN PATHOL, V61, P317, DOI 10.1136/jcp.2007.050336 | - |
dc.description.citedreference | Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017 | - |
dc.description.citedreference | Allred DC, 2008, CLIN CANCER RES, V14, P370, DOI 10.1158/1078-0432.CCR-07-1127 | - |
dc.description.citedreference | Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982 | - |
dc.description.citedreference | Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108 | - |
dc.description.citedreference | Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855 | - |
dc.description.citedreference | Charafe-Jauffret E, 2008, PATHOBIOLOGY, V75, P75, DOI 10.1159/000123845 | - |
dc.description.citedreference | Ginestier C, 2007, CELL STEM CELL, V1, P555 | - |
dc.description.citedreference | Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295 | - |
dc.description.citedreference | Campbell LL, 2007, CELL CYCLE, V6, P2332 | - |
dc.description.citedreference | Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013 | - |
dc.description.citedreference | Beaulieu LM, 2007, EXP CELL RES, V313, P677, DOI 10.1016/j.yexcr.2006.11.019 | - |
dc.description.citedreference | Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530 | - |
dc.description.citedreference | Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298 | - |
dc.description.citedreference | Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048 | - |
dc.description.citedreference | Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492 | - |
dc.description.citedreference | Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127 | - |
dc.description.citedreference | Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011 | - |
dc.description.citedreference | Polyak K, 2006, NAT MED, V12, P296, DOI 10.1038/nm1379 | - |
dc.description.citedreference | Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610 | - |
dc.description.citedreference | Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619 | - |
dc.description.citedreference | Abraham BK, 2005, CLIN CANCER RES, V11, P1154 | - |
dc.description.citedreference | Blanpain C, 2004, CELL, V118, P635 | - |
dc.description.citedreference | Nielsen TO, 2004, CLIN CANCER RES, V10, P5367 | - |
dc.description.citedreference | Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006 | - |
dc.description.citedreference | Kristiansen G, 2003, CLIN CANCER RES, V9, P4906 | - |
dc.description.citedreference | Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100 | - |
dc.description.citedreference | Park SY, 2002, HUM PATHOL, V33, P1078, DOI 10.1053/hupa.2002.129422 | - |
dc.description.citedreference | Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530 | - |
dc.description.citedreference | Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823 | - |
dc.description.citedreference | Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869 | - |
dc.description.citedreference | Perou CM, 2000, NATURE, V406, P747 | - |
dc.description.citedreference | Graff JR, 2000, J BIOL CHEM, V275, P2727 | - |
dc.description.citedreference | HEPPNER GH, 1983, CANCER METAST REV, V2, P5 | - |
dc.description.citedreference | NOWELL PC, 1976, SCIENCE, V194, P23 | - |
dc.description.tc | 42 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.